Introducing our latest innovation in COVID-19 testing – the Rtk Antigen Saliva Test. This ground-breaking test offers a convenient and non-invasive way to determine the presence of the virus by using a simple saliva sample. By detecting the SARS-CoV-2 antigen in saliva, this test provides fast and accurate results, making it an ideal solution for frequent testing in both clinical and non-clinical settings. The Rtk Antigen Saliva Test offers several advantages over traditional nasal swab tests. Firstly, collecting a saliva sample is more comfortable and less invasive, making it an attractive option for individuals who may be hesitant to undergo nasal swab testing. Additionally, the ease of sample collection makes it suitable for use in various settings, including schools, workplaces, and public health facilities. With the ability to provide results in a matter of minutes, the Rtk Antigen Saliva Test enables prompt decision-making and helps to quickly identify and isolate individuals who may be carrying the virus. This is crucial in controlling the spread of COVID-19 and protecting the health and safety of the community. We are proud to offer the Rtk Antigen Saliva Test as part of our commitment to providing accessible and reliable testing solutions for COVID-19. This innovative test exemplifies our dedication to leveraging cutting-edge technology to combat the pandemic and support a safer and healthier future for all.

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that